应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02196 复星医药
未开盘 09-22 16:08:13
18.090
-0.200
-1.09%
最高
18.440
最低
18.000
成交量
400.43万
今开
18.290
昨收
18.290
日振幅
2.41%
总市值
479.20亿
流通市值
96.06亿
总股本
26.49亿
成交额
7,269万
换手率
0.75%
流通股本
5.31亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
复星医药9月22日回购120万股股份,耗资约2,179.16万港元
公告速递 · 09-22 17:42
复星医药9月22日回购120万股股份,耗资约2,179.16万港元
复星医药(02196.HK)9月22日斥资2179.16万港元回购120万股
智通财经 · 09-22 17:40
复星医药(02196.HK)9月22日斥资2179.16万港元回购120万股
复星医药:控股股东解除约9903万股质押股份 质押比例降至62.62%
公告速递 · 09-21 17:55
复星医药:控股股东解除约9903万股质押股份 质押比例降至62.62%
复星医药9月21日回购27.15万股,耗资约486.23万港元
公告速递 · 09-21 17:36
复星医药9月21日回购27.15万股,耗资约486.23万港元
复星医药:9月21日斥资486.23万港元回购27.15万股
南方财经网 · 09-21 17:35
复星医药:9月21日斥资486.23万港元回购27.15万股
复星医药:控股股东复星高科技解除质押9902.50万股
南方财经网 · 09-21 16:33
复星医药:控股股东复星高科技解除质押9902.50万股
医美概念股多股上扬 三生制药(01530)涨5.71%、四环医药(00460)涨4.17%
金吾财讯 · 09-21 10:09
医美概念股多股上扬 三生制药(01530)涨5.71%、四环医药(00460)涨4.17%
复星医药:控股股东复星高科技新增质押2.25亿股并同步解押2.20亿股
公告速递 · 09-18
复星医药:控股股东复星高科技新增质押2.25亿股并同步解押2.20亿股
复星医药:9月18日回购130万股,耗资约2,277.01万港元
公告速递 · 09-18
复星医药:9月18日回购130万股,耗资约2,277.01万港元
复星医药(02196.HK)9月18日斥资2277.01万港元回购130万股
智通财经 · 09-18
复星医药(02196.HK)9月18日斥资2277.01万港元回购130万股
复星医药:复星高科技质押2.25亿股用于偿还债务
南方财经网 · 09-18
复星医药:复星高科技质押2.25亿股用于偿还债务
复星医药9月17日回购100万股,合计支付约1,719.30万港元
公告速递 · 09-17
复星医药9月17日回购100万股,合计支付约1,719.30万港元
复星医药:二级市场股价短期分时波动受多种因素综合影响
证券之星 · 09-17
复星医药:二级市场股价短期分时波动受多种因素综合影响
复星医药:该药品上市许可持有人(MAH)的变更工作正加快推进
证券之星 · 09-17
复星医药:该药品上市许可持有人(MAH)的变更工作正加快推进
复星医药2026年中期营收203.77亿元,经调整净利润11.44亿元
公告速递 · 09-17
复星医药2026年中期营收203.77亿元,经调整净利润11.44亿元
复星医药9月16日回购130万股股份,涉资约2,224.39万港元
公告速递 · 09-16
复星医药9月16日回购130万股股份,涉资约2,224.39万港元
复星医药(02196)9月16日耗资2224.386万港元回购130万股
智通财经 · 09-16
复星医药(02196)9月16日耗资2224.386万港元回购130万股
智通AH统计|9月16日
智通财经 · 09-16
智通AH统计|9月16日
复星医药:9月15日回购130万股股份
格隆汇 · 09-15
复星医药:9月15日回购130万股股份
复星医药回购130万股股份,涉资约2,207.07万港元
公告速递 · 09-15
复星医药回购130万股股份,涉资约2,207.07万港元
公司概况
公司名称:
复星医药
所属市场:
SEHK
上市日期:
--
主营业务:
上海复星医药(集团)股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司通过五个分部开展业务。制药分部主要从事药品的研发、生产和销售。医疗器械与医学诊断分部主要从事医疗器械和诊断产品的研发、生产和销售。医疗健康服务分部主要从事提供医疗健康服务及医院管理。医药分销和零售分部主要从事医药、器械分销和零售。 该公司还运营其他分部。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02196","market":"HK","secType":"STK","nameCN":"复星医药","latestPrice":18.09,"timestamp":1790064493005,"preClose":18.29,"halted":0,"volume":4004311,"delay":0,"changeRate":-0.010934937124111498,"floatShares":530999999,"shares":2649000000,"eps":1.4872882220060868,"marketStatus":"未开盘","change":-0.2,"latestTime":"09-22 16:08:13","open":18.29,"high":18.44,"low":18,"amount":72686064,"amplitude":0.024057,"askPrice":18.09,"askSize":500,"bidPrice":18.08,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":1.49900852163273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790127000000},"marketStatusCode":0,"adr":0,"listingDate":1351526400000,"exchange":"SEHK","adjPreClose":18.29,"dividendRate":0.025272,"openAndCloseTimeList":[[1790040600000,1790049600000],[1790053200000,1790064000000]],"volumeRatio":0.9030524862449698,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"复星医药","latestPrice":23.13,"timestamp":1790060400000,"preClose":23.05,"halted":0,"volume":31382400,"delay":0,"premium":"-33.22"}},"requestUrl":"/m/hq/s/02196/wiki","defaultTab":"wiki","newsList":[{"id":"1158774134","title":"复星医药9月22日回购120万股股份,耗资约2,179.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158774134","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158774134?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:42","pubTimestamp":1790070126,"startTime":"0","endTime":"0","summary":"复星医药于2026年9月22日发布公告称,公司当日在香港联交所回购1,200,000股H股,占回购前已发行股份总数约0.23%。回购价格介于每股18.01港元至18.23港元,总涉资约2,179.16万港元。本次回购后,公司已发行股份总数减至529,741,000股,库藏股数量增至22,199,500股。此前,公司于2026年6月16日召开的股东大会上通过了回购授权,授权回购股份总数为54,097,150股。公告同时指出,公司已按照香港联交所上市规则及相关法规合规开展本次回购事宜。公告由董事陈玉卿签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月22日回购120万股股份,耗资约2,179.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486721","title":"复星医药(02196.HK)9月22日斥资2179.16万港元回购120万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669486721?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:40","pubTimestamp":1790070038,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02196","BK1593","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115112298","title":"复星医药:控股股东解除约9903万股质押股份 质押比例降至62.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115112298","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115112298?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:55","pubTimestamp":1789984547,"startTime":"0","endTime":"0","summary":"2026年9月21日,复星医药公告称,控股股东上海复星高科技(集团)有限公司于2026年9月18日办理完成部分A股股份解除质押。涉及股份数量为99,025,000股,占复星高科技持股总数的10.30%,占公司截至2026年9月18日收市股份总数的3.71%。本次操作后,复星高科技持有复星医药股份总数为961,424,455股,其中A股889,890,955股、H股71,533,500股,持股比例维持36.00%。公告称,复星高科技后续仍存在对相关股份再质押的计划,未来如发生新的质押事宜,将按法规及时披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191127809","title":"复星医药9月21日回购27.15万股,耗资约486.23万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191127809","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191127809?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983362,"startTime":"0","endTime":"0","summary":"2026年9月21日,复星医药发布翌日披露报表,公告该公司于当日在香港联交所场内回购H股普通股,涉及股份数量为27.15万股,占公司现有已发行股本约0.05%。根据公告,本次回购价格区间为每股17.78港元至17.98港元,合计耗资约486.23万港元。公司于2026年6月16日通过回购授权,授权可回购股份总数为54,097,150股。按照有关规定,在此次回购后的一段时间内,公司将暂不进行新的股份发行或出售、转让任何库藏股,暂止期至2026年10月21日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月21日回购27.15万股,耗资约486.23万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669154429","title":"复星医药:9月21日斥资486.23万港元回购27.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669154429","media":"南方财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669154429?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:35","pubTimestamp":1789983300,"startTime":"0","endTime":"0","summary":"南财智讯9月21日电,复星医药(02196.HK)发布翌日披露报表,公司于2026年9月21日在香港联交所进行股份回购,回购股份数量为271500股,每股最高回购价17.98港元,每股最低回购价17.78港元,付出的总代价为4862335港元。该等回购股份拟持作库存股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880099430.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880099430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","BK0187","02196","600196","BK1593","BK0183","BK1515","BK0096","BK0012","BK0188","BK0060","BK1191","BK0196","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669596251","title":"复星医药:控股股东复星高科技解除质押9902.50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669596251","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669596251?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:33","pubTimestamp":1789979580,"startTime":"0","endTime":"0","summary":"南财智讯9月21日电,复星医药公告,公司于2026年9月21日接到控股股东上海复星高科技(集团)有限公司通知,其已将所持有的公司99,025,000股A股办理解除质押手续,解除质押时间为2026年9月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880040762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880040762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0196","BK1515","BK0187","BK0096","BK0183","BK0239","600196","02196","BK0028","BK0175","BK0188","BK1191","BK0012","BK1593","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669509139","title":"医美概念股多股上扬 三生制药(01530)涨5.71%、四环医药(00460)涨4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669509139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669509139?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:09","pubTimestamp":1789956581,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美概念股多股上扬,截至发稿,山东新华制药股份 涨10.81%,三生制药涨5.71%,四环医药涨4.17%,昊海生物科技涨3.82%,复星医药涨3.12%,现代牙科涨3.10%,时代天使涨2.25%。消息面上,国金证券表示,医美板块下游连锁景气回暖,上游平台化逻辑有望兑现,建议关注上游头部连锁化机构、需求扩容下具备强渠道能力的上游平台化标的。看好布局差异化赛道的上游医美产品厂商及满足医美新场景需求的下游医美机构。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992051","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","00719","BK1161","BK1100","02196","06826","BK1587","BK1593","03600","01530","BK1583","HK0000165453.HKD","06699","00460","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147791636","title":"复星医药:控股股东复星高科技新增质押2.25亿股并同步解押2.20亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147791636","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147791636?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:12","pubTimestamp":1789722738,"startTime":"0","endTime":"0","summary":"复星医药9月18日在香港联交所发布海外监管公告,披露控股股东上海复星高科技(集团)有限公司于2026年9月17日办理股份质押及解除质押事宜。复星高科技本次新增质押2.25亿股A股,质押起始日为2026年9月17日,到期日为2028年9月21日,质权人为中国工商银行股份有限公司上海市长宁支行。同日,复星高科技解除质押2.2025亿股A股,占其所持股份的22.91%,占公司总股本的8.25%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122876585","title":"复星医药:9月18日回购130万股,耗资约2,277.01万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122876585","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122876585?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:05","pubTimestamp":1789722348,"startTime":"0","endTime":"0","summary":"上海复星医药(集团)股份有限公司于2026年9月18日发布公告,披露当日于香港联交所场内回购1,300,000股H股,占回购前公司已发行股份总数约0.24%。本次回购每股价格介乎港币17.35元至17.58元,总耗资约港币22,770,110元。公告显示,本次回购完成后,公司已发行股份数仍为551,940,500股;其中已发行股份为531,212,500股,库藏股为20,728,000股。公司并披露,本次回购股份后再进行新股发行或出售库藏股的暂止期截至2026年10月18日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药:9月18日回购130万股,耗资约2,277.01万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668413439","title":"复星医药(02196.HK)9月18日斥资2277.01万港元回购130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668413439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668413439?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:57","pubTimestamp":1789721871,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02196","BK1515","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668357949","title":"复星医药:复星高科技质押2.25亿股用于偿还债务","url":"https://stock-news.laohu8.com/highlight/detail?id=2668357949","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668357949?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:17","pubTimestamp":1789719420,"startTime":"0","endTime":"0","summary":"南财智讯9月18日电,复星医药公告,公司控股股东上海复星高科技(集团)有限公司于2026年9月17日将其持有的22500万股A股股份办理质押,占其所持股份比例23.40%,占公司总股本比例8.43%,质押融资资金用途为偿还债务;同日解除质押22025万股A股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183878620972.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183878620972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK0196","BK0028","BK0187","02196","BK0239","BK0183","BK0175","BK0012","BK1191","BK1515","600196","BK0096","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113041658","title":"复星医药9月17日回购100万股,合计支付约1,719.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113041658","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113041658?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:46","pubTimestamp":1789638398,"startTime":"0","endTime":"0","summary":"复星医药于2026年9月17日发布翌日报表公告,披露于同日回购H股100万股,约占2026年9月16日公司已发行股份总数的0.19%。据公告,本次回购所涉及的股价在每股17.07港元至17.29港元之间,合计支付价格约1,719.30万港元。回购完成后,公司已发行股份为532,512,500股,库存股份增加至19,428,000股,股本总数保持551,940,500股。该次回购基于公司于2026年6月16日通过的购回授权,公司可回购股份总数为54,097,150股,截至目前已回购8,459,000股,占授权通过当日已发行股份总数的1.56%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月17日回购100万股,合计支付约1,719.30万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668632239","title":"复星医药:二级市场股价短期分时波动受多种因素综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2668632239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668632239?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:42","pubTimestamp":1789638125,"startTime":"0","endTime":"0","summary":"证券之星消息,复星医药(600196)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘:公司是怎么做到复星医药分时走势与化学制药高度一致的?复星医药回复:投资者您好!二级市场股价短期分时波动受多种因素综合影响,包括市场整体环境、投资者交易行为、资金流向及市场情绪等,具有较强的市场交易属性。公司直接运营业务包括制药、器械诊断与医疗健康服务,并通过参股国药控股进一步覆盖药械分销零售领域。感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。相关 ETF责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700027747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0175","BK1191","BK0028","BK0012","BK0183","BK1593","BK0187","02196","600196","BK0196","BK0188","BK1515","BK0060","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963224","title":"复星医药:该药品上市许可持有人(MAH)的变更工作正加快推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668963224?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:39","pubTimestamp":1789637953,"startTime":"0","endTime":"0","summary":"证券之星消息,复星医药(600196)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:公司收购智翔金泰GR1803,请问目前技术转移进展如何?产品销售情况如何?复星医药回复:投资者您好!该药品上市许可持有人(MAH)的变更工作正加快推进,相关商业化筹备就绪。感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。相关 ETF责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700027673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0012","BK0175","BK0028","02196","BK0187","BK1515","BK0060","BK0188","BK0196","BK0239","600196","BK0183","BK1593","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127114335","title":"复星医药2026年中期营收203.77亿元,经调整净利润11.44亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127114335","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127114335?lang=zh_cn&edition=full","pubTime":"2026-09-17 16:21","pubTimestamp":1789633300,"startTime":"0","endTime":"0","summary":"本季度信息显示,复星医药在2026年上半年实现营收203.77亿元,同比增长4.9%。公司经调整净利润达11.44亿元,同比增长21.97%。报告期内,经营活动产生的现金流量净额为24.24亿元,同比增长13.59%。研发投入为32.47亿元,同比增长25.66%,占营收比例15.88%。业务分项方面,制药板块收入147.27亿元,同比增长6.59%;医疗器械与医学诊断板块收入18.59亿元,同比下降4.81%;医疗健康服务板块实现收入37.35亿元,同比增长4.07%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"复星医药2026年中期营收203.77亿元,经调整净利润11.44亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140845888","title":"复星医药9月16日回购130万股股份,涉资约2,224.39万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1140845888","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140845888?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:02","pubTimestamp":1789552970,"startTime":"0","endTime":"0","summary":"2026年9月16日,上海复星医药(集团)股份有限公司公告称,于当日在香港联交所场内以每股16.91港元至17.26港元的价格回购H股共计1,300,000股,约占公司当日已发行股本0.24%,总计支付约22,243,860港元。本次回购股份将以库藏股方式持有。本次回购完成后,公司已发行股份总数维持在551,940,500股,其中在外流通股份增至533,512,500股,库藏股数量增至18,428,000股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药9月16日回购130万股股份,涉资约2,224.39万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667060414","title":"复星医药(02196)9月16日耗资2224.386万港元回购130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667060414","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667060414?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:56","pubTimestamp":1789552573,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(02196)公布,2026年9月16日耗资2224.386万港元回购130万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK1515","BK0096","HELS","BK0175","BK0188","BK1593","BK1191","BK0196","BK0060","BK0028","BK0239","02196","BK0183","BK0187","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667058605","title":"智通AH统计|9月16日","url":"https://stock-news.laohu8.com/highlight/detail?id=2667058605","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667058605?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:15","pubTimestamp":1789546507,"startTime":"0","endTime":"0","summary":"东北电气0.2282.251084.21%43.40%浙江世宝3.78515.42387.98%5.78%凯盛新能2.2308.88377.13%101.85%弘业期货2.1557.86336.66%18.58%安德利果汁24.26081.59302.84%31.56%晨鸣纸业0.6052.01298.35%27.96%南京熊猫电子股份3.0309.71283.83%26.68%中石化油服0.7102.23276.06%-29.79%钧达股份11.97037.54275.69%57.80%复旦张江2.4907.52261.85%-20.02%. 宁德时代501.000333.86-20.18%6.48%招商银行51.35040.79-4.85%-0.38%中际旭创1137.000907.8-4.37%-3.14%药明康德195.100157.71-3.17%0.49%兆易创新450.000373.14-0.68%1.76%潍柴动力29.56026.045.51%2.71%美的集团98.65087.235.91%1.41%立讯精密58.50052.898.29%-2.03%交通银行8.1257.5811.75%-1.19%紫金矿业34.42032.1711.94%0.01%. 备注:以上数据由智通机器人根据港交所数据,经过人工智能运算后自动生成,并不保证数据100%准确;偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02827","03200","09981","02865","399300","IE0008368742.USD","01377","02359","03143","LU1328277881.USD","07233","02475","01057","03188","02883","83188","03968","01812","02701","02208","82846","02196","03678","00553","BK1576","03308","EWH","00317","03130","02218","02009","00300","06821","LU2778985437.USD","03328","83130","01349","LU0823426308.USD","02846","06745","00042","01033","02899","03986","03750","159982","01108","02338","00991"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667936645","title":"复星医药:9月15日回购130万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2667936645","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667936645?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:58","pubTimestamp":1789466293,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02196","BK1593","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144415776","title":"复星医药回购130万股股份,涉资约2,207.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144415776","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144415776?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:53","pubTimestamp":1789465988,"startTime":"0","endTime":"0","summary":"上海复星医药(集团)股份有限公司于2026年9月15日发布翌日披露报表,公告当日通过香港联交所场内回购股份。根据公告,复星医药于2026年9月15日回购H股普通股1,300,000股,约占公司现有已发行股份总数的0.24%。本次回购价介乎每股16.89港元至17.10港元之间,总金额约2,207.07万港元。公告披露,复星医药于2026年6月16日通过本次购回股份的授权,可回购股份总数为54,097,150股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复星医药回购130万股股份,涉资约2,207.07万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fosunpharma.com","stockEarnings":[{"period":"1week","weight":0.0685},{"period":"1month","weight":0.0415},{"period":"3month","weight":0.1874},{"period":"6month","weight":-0.011},{"period":"1year","weight":-0.3208},{"period":"ytd","weight":-0.0495}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":-0.0354},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.0093},{"period":"1year","weight":-0.0477},{"period":"ytd","weight":-0.0212}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复星医药(集团)股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司通过五个分部开展业务。制药分部主要从事药品的研发、生产和销售。医疗器械与医学诊断分部主要从事医疗器械和诊断产品的研发、生产和销售。医疗健康服务分部主要从事提供医疗健康服务及医院管理。医药分销和零售分部主要从事医药、器械分销和零售。 该公司还运营其他分部。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044495},{"month":2,"riseRate":0.714286,"avgChangeRate":0.036179},{"month":3,"riseRate":0.571429,"avgChangeRate":0.044259},{"month":4,"riseRate":0.357143,"avgChangeRate":0.026},{"month":5,"riseRate":0.428571,"avgChangeRate":0.024935},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.032656},{"month":7,"riseRate":0.642857,"avgChangeRate":0.03393},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.040558},{"month":9,"riseRate":0.5,"avgChangeRate":0.020164},{"month":10,"riseRate":0.461538,"avgChangeRate":0.020365},{"month":11,"riseRate":0.428571,"avgChangeRate":0.034477},{"month":12,"riseRate":0.428571,"avgChangeRate":0.015129}],"exchange":"SEHK","name":"复星医药","nameEN":"FOSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复星医药,02196,复星医药股票,复星医药股票老虎,复星医药股票老虎国际,复星医药行情,复星医药股票行情,复星医药股价,复星医药股市,复星医药股票价格,复星医药股票交易,复星医药股票购买,复星医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}